HBIO Financial Facts
Net Income: -1.64MInterest expense: -142K
See Full Income Statement
Additional paid-in-capital: 214.13M
Amortizable intangible assets, net: 18.86M
See Full Balance Sheet
Harvard Bioscience (HBIO) Earnings
|
Expand Research on HBIO
| Next EPS Date | 11/10/26 | EPS Growth Rate | -800.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -146.7% | Revenue Growth Rate | +6.1% |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | -$0.27 | N/A | N/A | $21.85M | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.14 | -$0.38 | +$0.24 | $22.73M | $21.9M | N/A |  | | Details | |
| 4/30/26 |
Q126 | N/A | -$0.01 | N/A | N/A | $21.25M | N/A | N/A | N/A | ||
| 3/12/26 | Q425 | -$0.06 | $0.04 | -$0.10 | $23.7M | $23.1M | N/A | | | Details | |
| 11/6/25 | Q325 | -$0.03 | $0.01 | -$0.04 | $20.6M | $19M | N/A | | | Details | |
| 8/11/25 |
Q225 | N/A | -$0.01 | N/A | N/A | $21.4M | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | -$0.01 | -$0.01 | $0.00 | $21.77M | $20M | N/A | | | Details | |
| 3/12/25 | Q424 | $0.06 | $0.05 | +$0.01 | $24.6M | $24.15M | = | | | Details |
